Cargando…

Utilization of blood by-products: An in silico and experimental combined study for BSA usage

In order to exploit industrial discards, protein enzymatic hydrolysis is a currently popular methodology for obtaining bioactive peptides. However, once released, most promising peptides have to be selected from the mixture. In this work, the suitability of pepsin (EC 3.4.23.1) to hydrolyse serum al...

Descripción completa

Detalles Bibliográficos
Autores principales: Arrutia, Fátima, Fernández, Rebeca, Menéndez, Carlos, González, Ulises A., Riera, Francisco A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722935/
https://www.ncbi.nlm.nih.gov/pubmed/29222431
http://dx.doi.org/10.1038/s41598-017-17029-2
_version_ 1783285108441088000
author Arrutia, Fátima
Fernández, Rebeca
Menéndez, Carlos
González, Ulises A.
Riera, Francisco A.
author_facet Arrutia, Fátima
Fernández, Rebeca
Menéndez, Carlos
González, Ulises A.
Riera, Francisco A.
author_sort Arrutia, Fátima
collection PubMed
description In order to exploit industrial discards, protein enzymatic hydrolysis is a currently popular methodology for obtaining bioactive peptides. However, once released, most promising peptides have to be selected from the mixture. In this work, the suitability of pepsin (EC 3.4.23.1) to hydrolyse serum albumin in order to obtain bioactive peptides was assessed. Then, a suitable process to obtain best separation of bioactive peptides was evaluated, using polyethersulfone membranes at different pH values. Serum albumin was easily hydrolysed by pepsin, reaching a DH value of the 65.64 ± 1.57% of the maximum possible. A 23.25% of the identified peptides possessed high bioactivity scores (greater than 0.5), and one of them had reported bioactivity (LLL). Charge mechanisms always predominated over the sieve effect, and best transmission was accomplished at pH values close to the peptides isoelectric points. Basic and neutral peptides with the highest scores were always the most transmitted. Membrane material had greater influence than NMWCO in determining peptide transmission. In order to obtain purified fractions rich in peptides with high bioactivity scores from serum albumin, polyethersulfone membranes (applicable to industrial scale) of 5 kDa MWCO should be used at basic pH values after pepsin digestion.
format Online
Article
Text
id pubmed-5722935
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-57229352017-12-12 Utilization of blood by-products: An in silico and experimental combined study for BSA usage Arrutia, Fátima Fernández, Rebeca Menéndez, Carlos González, Ulises A. Riera, Francisco A. Sci Rep Article In order to exploit industrial discards, protein enzymatic hydrolysis is a currently popular methodology for obtaining bioactive peptides. However, once released, most promising peptides have to be selected from the mixture. In this work, the suitability of pepsin (EC 3.4.23.1) to hydrolyse serum albumin in order to obtain bioactive peptides was assessed. Then, a suitable process to obtain best separation of bioactive peptides was evaluated, using polyethersulfone membranes at different pH values. Serum albumin was easily hydrolysed by pepsin, reaching a DH value of the 65.64 ± 1.57% of the maximum possible. A 23.25% of the identified peptides possessed high bioactivity scores (greater than 0.5), and one of them had reported bioactivity (LLL). Charge mechanisms always predominated over the sieve effect, and best transmission was accomplished at pH values close to the peptides isoelectric points. Basic and neutral peptides with the highest scores were always the most transmitted. Membrane material had greater influence than NMWCO in determining peptide transmission. In order to obtain purified fractions rich in peptides with high bioactivity scores from serum albumin, polyethersulfone membranes (applicable to industrial scale) of 5 kDa MWCO should be used at basic pH values after pepsin digestion. Nature Publishing Group UK 2017-12-08 /pmc/articles/PMC5722935/ /pubmed/29222431 http://dx.doi.org/10.1038/s41598-017-17029-2 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Arrutia, Fátima
Fernández, Rebeca
Menéndez, Carlos
González, Ulises A.
Riera, Francisco A.
Utilization of blood by-products: An in silico and experimental combined study for BSA usage
title Utilization of blood by-products: An in silico and experimental combined study for BSA usage
title_full Utilization of blood by-products: An in silico and experimental combined study for BSA usage
title_fullStr Utilization of blood by-products: An in silico and experimental combined study for BSA usage
title_full_unstemmed Utilization of blood by-products: An in silico and experimental combined study for BSA usage
title_short Utilization of blood by-products: An in silico and experimental combined study for BSA usage
title_sort utilization of blood by-products: an in silico and experimental combined study for bsa usage
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722935/
https://www.ncbi.nlm.nih.gov/pubmed/29222431
http://dx.doi.org/10.1038/s41598-017-17029-2
work_keys_str_mv AT arrutiafatima utilizationofbloodbyproductsaninsilicoandexperimentalcombinedstudyforbsausage
AT fernandezrebeca utilizationofbloodbyproductsaninsilicoandexperimentalcombinedstudyforbsausage
AT menendezcarlos utilizationofbloodbyproductsaninsilicoandexperimentalcombinedstudyforbsausage
AT gonzalezulisesa utilizationofbloodbyproductsaninsilicoandexperimentalcombinedstudyforbsausage
AT rierafranciscoa utilizationofbloodbyproductsaninsilicoandexperimentalcombinedstudyforbsausage